Inhibrx Biosciences, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
INBX Company Description
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what they believe to be the most appropriate agonist function.
INBX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view INBX Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of INBX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by INBX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of INBX in WallStreetBets Daily Discussion
INBX News
Recent insights relating to INBX
CNBC Recommendations
Recent picks made for INBX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in INBX
Corporate Flights
Flights by private jets registered to INBX
Our Analysis